+ {/*
*/}
{/* Market Opportunity & Exit */}
- The Funding Challenge
@@ -112,10 +112,10 @@ export function DeRiskedPath() {
Breakthrough cancer research is traditionally capital-intensive, often leading to significant equity dilution for early investors.
-
+
diff --git a/src/app/components/Footer.tsx b/src/app/components/Footer.tsx
index ff90f0f..c8b2bda 100644
--- a/src/app/components/Footer.tsx
+++ b/src/app/components/Footer.tsx
@@ -17,7 +17,7 @@ export function Footer({
{/* Brand Column */}
Market Opportunity & Exit
@@ -166,7 +166,7 @@ export function DeRiskedPath() {
diff --git a/src/app/components/FlowVaxProvenScience.tsx b/src/app/components/FlowVaxProvenScience.tsx
index df7bb5a..9e0c85a 100644
--- a/src/app/components/FlowVaxProvenScience.tsx
+++ b/src/app/components/FlowVaxProvenScience.tsx
@@ -45,7 +45,7 @@ export function FlowVaxProvenScience() {
Full SARS-CoV-2 Protection
Reinvest Capital into Oncology
- Programs: Direct the funding generated in Step 1 to advanced Glioblastoma (GBM) and other cancer vaccines into Phase 1/2 clinical trials. + Programs: Direct the funding generated in Step 1 to advance Glioblastoma (GBM) and other cancer vaccines into Phase 1/2 clinical trials.
- Vaccination resulted in full protection against severe infection and virus-associated pneumonia in Rhesus Macaques + Vaccination resulted in full protection against virus-associated pneumonia in Rhesus Macaques.
- 
+ 
A next-generation biotech company pioneering patented viral and oncology immunotherapies with a clear, de-risked path to commercialization. @@ -81,9 +81,8 @@ export function Footer({
- Level 4, 11 Biotech Way
- Sydney, NSW 2000, Australia + 924 East 7th St #200
+ Austin TX 78702
diff --git a/src/app/components/MeetTeam.tsx b/src/app/components/MeetTeam.tsx
new file mode 100644
index 0000000..7373d26
--- /dev/null
+++ b/src/app/components/MeetTeam.tsx
@@ -0,0 +1,169 @@
+import { useEffect, useState } from "react";
+import { IMAGES } from "../../constants/images";
+import svgPaths from "../../imports/svg-6oa7gxdabo";
+import { OurTeamPageContent } from "./OurTeamPageContent";
+import { AnimatePresence, motion } from 'motion/react';
+import { TeamMemberDetail } from "./TeamMemberDetail";
+
+
+const data = {
+ members: [
+ {
+ name: "Reid Rubsamen",
+ role: "MD. Chairman of the Board",
+ image: IMAGES.ourTeams.ReidRubsamen,
+ description: "Dr. Reid Rubsamen is the visionary founder and CEO of Flow Pharma. A board-certified anesthesiologist with training at Massachusetts General Hospital (where he served as Chief Resident) and advanced degrees in both computer science and medicine from UC Berkeley and Stanford, Reid bridges the worlds of technology and healthcare. He previously founded two medical technology companies (including Aradigm Corporation) before launching Flow Pharma. An inventor at heart, he holds over 70 U.S. patents and has more than 10,000 citations to his scientific work – clear evidence of his innovative impact. Despite these accomplishments, Reid is known for his down-to-earth leadership and enthusiasm for mentoring others. He brings to the board not only profound expertise but also a genuine passion for collaboration and breakthrough innovation that inspires everyone around him."
+ },
+ {
+ name: "Paul Harris",
+ role: "Ph.D. Chief Science Officer",
+ image: IMAGES.ourTeams.PaulHarris,
+ description: "Paul Harris received his undergraduate degree from the University of California, Berkeley in Biochemistry and Medical Biophysics, his PhD in Cell Biology from Cornell University, and did Postdoctoral training in peptide chemistry at The Rockefeller University. He was a faculty member at the health sciences campus of Columbia University since 1988, most recently as an Associate Professor in Medical Science (in Medicine) in the medical school. Dr Harris' research efforts spanning 1990 to 2010 were instrumental in defining the structure of MHC bound peptides and dendritic cell therapy. Studies he co-authored provided the foundations for current vaccine design strategies."
+ },
+ {
+ name: "CV Herst",
+ role: "Ph.D. Senior Scientist",
+ image: IMAGES.ourTeams.CVHerst,
+ description: "C.V. Herst received his undergraduate degree in Bacteriology and his master's degree in Public Health from U.C. Berkeley, after which he was hired by Cetus Corporation, one of the original biotechnology companies, where he was on the cloning teams for IFN-beta, IL-2, and TNF-alpha. In 1989 he earned his Ph.D. in Tumor Cell Biology from Northwestern University. In his post-doctoral fellowship at MD Anderson Cancer Center, he researched bcr-abl breakpoint variations in chronic myelogenous leukemia. His career research efforts have led to approved therapies for systemic fungal infections, Multiple Sclerosis, certain cancers, as well as FDA approvals for medical devices. He has been a member of the Flow Pharma team since 2004."
+ },
+ ]
+}
+interface TeamMember {
+ name: string;
+ role: string;
+ image: string;
+ description?: string;
+}
+
+export function MeetTeam() {
+ const [isTeamOpen, setIsTeamOpen] = useState(false);
+ const [isScrolled, setIsScrolled] = useState(false);
+ const [selectedMember, setSelectedMember] = useState(null);
+
+ useEffect(() => {
+ const handleScroll = () => {
+ setIsScrolled(window.scrollY > 50);
+ };
+
+ window.addEventListener('scroll', handleScroll);
+ return () => window.removeEventListener('scroll', handleScroll);
+ }, []);
+
+ useEffect(() => {
+ if (isTeamOpen) {
+ setIsScrolled(false);
+ }
+ }, [isTeamOpen]);
+
+ return (
+
+
+
+ {isTeamOpen && (
+
+
+ {selectedMember && (
+ setSelectedMember(null)}
+ />
+ )}
+
+
+ )
+}
\ No newline at end of file
diff --git a/src/app/components/OurTeamPageContent.tsx b/src/app/components/OurTeamPageContent.tsx
index bab7d7e..c702613 100644
--- a/src/app/components/OurTeamPageContent.tsx
+++ b/src/app/components/OurTeamPageContent.tsx
@@ -65,6 +65,12 @@ const teamData = {
image: IMAGES.ourTeams.team7,
description: "Borys Chabursky is a strategist extraordinaire in the life sciences arena, bringing decades of experience in guiding healthcare innovation. He is the founder and chairman of Shift Health, where he has led over 500 health science initiatives for more than 300 clients worldwide. Through this work, Borys has helped organizations craft business plans and partnerships that leveraged over $1 billion in funding for biomedical research and innovation. He has a proven talent for building bridges across sectors – facilitating dozens of public–private partnerships in biotech and global health, and advising stakeholders from pharmaceutical companies and hospital networks to government policymakers. Borys has also personally mentored startups (even stepping in as interim CEO for several) and seeded new ventures with angel funding. Colleagues know him as a big-picture thinker with a collaborative spirit; he excels at bringing together diverse experts to solve complex challenges. Despite his far-reaching network and achievements, Borys remains deeply committed to the human side of healthcare – he's driven by a passion to improve global health and ensure innovations reach those who need them. We are fortunate to have his wise, steady guidance and his knack for inspiring teamwork on our board."
},
+ {
+ name: "John Brady",
+ role: "B.Sc.",
+ image: IMAGES.ourTeams.team18,
+ description: ""
+ }
],
management: [
{
diff --git a/src/app/components/PatentProtection.tsx b/src/app/components/PatentProtection.tsx
index aff0e23..55f8822 100644
--- a/src/app/components/PatentProtection.tsx
+++ b/src/app/components/PatentProtection.tsx
@@ -13,7 +13,7 @@ export function PatentProtection() {
Securing the Future of FlowVax
@@ -76,7 +76,7 @@ export function PatentProtection() {
+
+ Meet our Team
+
+
+
+ Meet our Team
+ Driven by Purpose, Powered by People
+
+ + Meet the scientists, innovators, and visionaries engineering a world without borders to immunity. +
+
+
+ {/* Slide-up Team Page Modal */}
+
+ {data.members.map((member, idx) => (
+
+ setSelectedMember(member)}
+ >
+
+ ))}
+
+
+ 
+
+ {/* Plus Icon */}
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+ {member.name}
+{member.role}
+
+
+
+
+
+ {/* Backdrop */}
+
+
+
+ )}
+ {
+ const scrollTop = e.currentTarget.scrollTop;
+ setIsScrolled(scrollTop > 50);
+ }}
+ >
+ setIsTeamOpen(false)} />
+
+ - Securing exclusive rights and ensuring global growth for Flow Pharma's innovative cancer vaccine platform + Securing exclusive rights and ensuring global growth for Flow Pharma's innovative vaccine platform
-
Global Jurisdictional Reach
+Global Reach
Robust protection established across multiple international territories.
diff --git a/src/app/components/TeamMemberDetail.tsx b/src/app/components/TeamMemberDetail.tsx index 042fc17..b0e868c 100644 --- a/src/app/components/TeamMemberDetail.tsx +++ b/src/app/components/TeamMemberDetail.tsx @@ -28,7 +28,7 @@ export function TeamMemberDetail({ member, onClose }: TeamMemberDetailProps) { className="absolute inset-0 bg-black/60 backdrop-blur-sm" onClick={onClose} /> - + {/* Modal Content */}
{/* Image Section */}
-
-
@@ -98,7 +98,7 @@ function Image1() {
return (
-
+
diff --git a/src/constants/images.ts b/src/constants/images.ts
index 243ed96..59aae6d 100644
--- a/src/constants/images.ts
+++ b/src/constants/images.ts
@@ -4,12 +4,13 @@ const filterPath = (path: string) => path.replace("/public/", "/");
export const IMAGES = {
homepage: {
- bg: "/assets/images/home-bg.png",
- logo: "/assets/images/logo.png",
- logoWhite: "/assets/images/logoWhite.png",
- patentProtection1: "/assets/images/patentProtection1.png",
- patentProtection2: "/assets/images/patentProtection2.png",
- flowVax: "/assets/images/flowVax.png",
+ bg: filterPath("/assets/images/home-bg.png"),
+ logo: filterPath("/assets/images/logo.png"),
+ logoWhite: filterPath("/assets/images/logoWhite.png"),
+ patentProtection1: filterPath("/assets/images/patentProtection1.png"),
+ patentProtection2: filterPath("/assets/images/patentProtection2.png"),
+ flowVax: filterPath("/assets/images/flowVax1.png"),
+ viewAllIcon: filterPath("/assets/icons/view.png"),
},
ourTeams: {
@@ -30,7 +31,11 @@ export const IMAGES = {
team15: "/assets/images/team15.png",
team16: "/assets/images/team16.png",
team17: "/assets/images/team17.png",
+ team18: "/assets/images/team18.png",
blank: "/assets/images/blank.png",
+ ReidRubsamen: "/assets/images/ReidRubsamen.png",
+ PaulHarris: "/assets/images/PaulHarris.png",
+ CVHerst: "/assets/images/CVHerst.png",
},
safe: {
diff --git a/src/imports/PatentProtection.tsx b/src/imports/PatentProtection.tsx
index 2908cf3..545be2f 100644
--- a/src/imports/PatentProtection.tsx
+++ b/src/imports/PatentProtection.tsx
@@ -22,7 +22,7 @@ function Image() {
return (
+
- 
+ {/* */}
-
+ {/* */}